You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 66 No. 2, February 2009 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Original Article
 •Online Features
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (15)
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Psychiatry
 •Depression
 •Women's Health
 •Pregnancy and Breast Feeding
 •Diagnosis
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Risk of Postpartum Depressive Symptoms With Elevated Corticotropin-Releasing Hormone in Human Pregnancy

Ilona S. Yim, PhD; Laura M. Glynn, PhD; Christine Dunkel Schetter, PhD; Calvin J. Hobel, MD; Aleksandra Chicz-DeMet, PhD; Curt A. Sandman, PhD

Arch Gen Psychiatry. 2009;66(2):162-169.

Context  Postpartum depression (PPD) is common and has serious implications for the mother and her newborn infant. A possible link between placental corticotropin-releasing hormone (pCRH) and PPD incidence has been hypothesized, but empirical evidence is lacking.

Objective  To determine whether accelerated increases in pCRH throughout pregnancy are associated with PPD symptoms.

Design  Pregnant women were recruited into this longitudinal cohort study. Blood samples were obtained at 15, 19, 25, 31, and 37 weeks' gestational age (GA) for assessment of pCRH, cortisol, and adrenocorticotropic hormone (ACTH). Depressive symptoms were assessed with a standardized questionnaire at the last 4 pregnancy visits and post partum.

Setting  Subjects were recruited from 2 southern California medical centers, and visits were conducted in research laboratories.

Participants  One hundred adult women with a singleton pregnancy.

Main Outcome Measure  Symptoms of PPD were assessed at a mean (SD) of 8.7 (2.94) weeks after delivery with the Edinburgh Postnatal Depression Scale.

Results  Sixteen women developed PPD symptoms. At 25 weeks' GA, pCRH was a strong predictor of PPD symptoms (R2 = 0.21; β = 0.46 [P < .001]), an effect that remained significant after controlling for prenatal depressive symptoms. No significant associations were found for cortisol and ACTH. Receiver operating characteristic curve analyses revealed that pCRH at 25 weeks' GA is a possible diagnostic tool (area under the curve, 0.78 [P = .001]). Sensitivity (0.75) and specificity (0.74) at the ideal cutoff point (pCRH, 56.86 pg/mL) were moderate. Growth curve analyses indicated that the trajectories of pCRH in women with PPD symptoms are significantly accelerated from 23 to 26 weeks' GA.

Conclusions  At a critical period in midpregnancy, pCRH is a sensitive and specific early diagnostic test for PPD symptoms. If replicated, these results have implications for the identification and treatment of pregnant women at risk for PPD.


Author Affiliations: Departments of Psychology and Social Behavior (Dr Yim), and Psychiatry and Human Behavior (Drs Glynn, Chicz-DeMet, and Sandman), University of California, Irvine; Department of Psychology, University of California, Los Angeles (Dr Dunkel Schetter); Division of Maternal-Fetal Medicine, Cedars-Sinai Medical Center, Los Angeles, California (Dr Hobel); and Department of Psychology, Chapman University, Orange, California (Dr Glynn).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTER

Premature Recommendation of Corticotropin-Releasing Hormone as Screen for Postpartum Depression
Janet Rich-Edwards, Michele Hacker, and Matthew Gillman
Arch Gen Psychiatry. 2009;66(8):917.
EXTRACT | FULL TEXT  

RELATED ARTICLE

This Month in Archives of General Psychiatry
Arch Gen Psychiatry. 2009;66(2):121.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Prescient Human Fetuses Thrive
Sandman et al.
Psychological Science 2012;23:93-100.
ABSTRACT | FULL TEXT  

Prenatal Origins of Neurological Development: A Critical Period for Fetus and Mother
Glynn and Sandman
Current Directions in Psychological Science 2011;20:384-389.
ABSTRACT | FULL TEXT  

Elevated Corticotropin Releasing Hormone (CRH) during Pregnancy and Risk of Postpartum Depression (PPD)
Meltzer-Brody et al.
J. Clin. Endocrinol. Metab. 2011;96:E40-E47.
ABSTRACT | FULL TEXT  

Maternal Coping Style and Perceived Adequacy of Income Predict CRH Levels at 14-20 Weeks of Gestation
Latendresse and Ruiz
Biol Res Nurs 2010;12:125-136.
ABSTRACT  

Chapter 18 Postnatal depression
Turjanski
Oxford Textbook of Women and Mental Health 2010;1:med-9780199214365-chapter-med-9780199214365-chapter.
ABSTRACT | FULL TEXT  

Premature Recommendation of Corticotropin-Releasing Hormone as Screen for Postpartum Depression
Rich-Edwards et al.
Arch Gen Psychiatry 2009;66:917-917.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.